Herantis Announces Election of Hilde Furberg to the Board of Directors
Herantis Pharma Plc Company release 15 April 2021 at 4:50 PM EET Herantis Pharma Plc (“Herantis or the Company”) focuses on disease modifying therapies for debilitating neurodegenerative diseases, today announced the election of Hilde Furberg to the Herantis Board of Directors, effective 15 April 2021. "We are pleased to welcome Hilde Furberg to the Herantis Board," said Timo Veromaa, Chairman of Herantis. "Hilde's deep experience in private and public Pharma/Biotech global businesses with strong global sales, marketing, strategy and management oversight will be invaluable to